 |
rituximab and recombinant human hyaluronidase |
|---|---|
| Trade Name | Rituxin Sc |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-22 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 |
